Analysts

Text size: A A A
Subscription
Site map
Français
Home

Model and picture are being used for illustrative purposes only.

Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investor Relations

Financial reports
Analysts
Investor information
Corporate governance
Request for information

Canaccord Adams, Neil Maruoka (416) 869-3073

Desjardins Securities, Maher Yaghi (514) 281-8664

Dundee Securities, David Martin (416) 350-3477

GMP Securities, Cosme Ordonez (514) 288-9279

Versant Partners, Douglas W. Loe (416) 849-5005

Theratechnologies Inc. is followed by the analysts indicated above. The opinions, estimates or forecasts made by these analysts do not reflect the opinions, estimates or forecasts of Theratechnologies Inc. or its management. By referring to the above, Theratechnologies Inc. in no way endorses these opinions, estimates and forecasts.